FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeffrey Frelinger

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Eda K Holl; Scott Plevy; Kelly E Roney; Erin Steinbach; Irving C Allen; Janelle C Arthur; Adam Buntzman; Jeffrey Frelinger; Jenny P-Y Ting
Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production.
Siobhán C Cowley; Anda I Meierovics; Jeffrey Frelinger; Yoichiro Iwakura; Karen L Elkins
Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
Benjamin G Vincent; Ellen F Young; Adam S Buntzman; Rosemary Stevens; Thomas B Kepler; Roland Tisch; Jeffrey Frelinger; Paul R Hess
Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeffrey Frelinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Eda K Holl; Scott Plevy; Kelly E Roney; Erin Steinbach; Irving C Allen; Janelle C Arthur; Adam Buntzman; Jeffrey Frelinger; Jenny P-Y Ting
Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production.
PloS one 2012;7(8):e43333.
2010: Siobhán C Cowley; Anda I Meierovics; Jeffrey Frelinger; Yoichiro Iwakura; Karen L Elkins
Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(10):5791-801.
2010: Benjamin G Vincent; Ellen F Young; Adam S Buntzman; Rosemary Stevens; Thomas B Kepler; Roland Tisch; Jeffrey Frelinger; Paul R Hess
Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(8):4196-204.
2010: Lisa Lindesmith; Eric Donaldson; Juan Leon; Christine Moe; Jeffrey Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Heterotypic humoral and cellular immune responses following Norwalk virus infection.
Journal of virology 2010;84(4):1800-15.
2009: Li Li; Qiuming He; Alaina Garland; Zuoan Yi; Lydia T Aybar; Thomas B Kepler; Jeffrey Frelinger; Bo Wang; Roland Tisch
beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(11):7585-91.
2009: Chengwen Li; Kevin Goudy; Matt Hirsch; Aravind Asokan; Yun Fan; Jeff Alexander; Junjiang Sun; Paul E Monahan; David Seiber; John Sidney; Alessandro Sette; Roland Tisch; Jeffrey Frelinger; R Jude Samulski
Cellular immune response to cryptic epitopes during therapeutic gene transfer.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(26):10770-4.
2009: Michael D Valentino; Lucinda L Hensley; Denise Skrombolas; Pamela L McPherson; Matthew D Woolard; Thomas H Kawula; Jeffrey Frelinger; john frelinger
Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.
Molecular immunology 2009;46(8-9):1830-8.
2009: Ellen F Young; Paul R Hess; LW Arnold; Roland Tisch; Jeffrey Frelinger
Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct.
Autoimmunity 2009;42(8):678-91.
2008: Joshua D Hall; Matthew D Woolard; Bronwyn M Gunn; Robin R Craven; Sharon Taft-Benz; Jeffrey Frelinger; Thomas H Kawula
Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.
Infection and immunity 2008;76(12):5843-52.
2008: Jeffrey Frelinger
Novel epitope begets a novel pathway in type 1 diabetes progression.
The Journal of clinical investigation 2008;118(10):3268-71.
2008: Li Li; Bo Wang; Jeffrey Frelinger; Roland Tisch
T-cell promiscuity in autoimmune diabetes.
Diabetes 2008;57(8):2099-106.
2008: David S Riddle; Peter J Miller; Benjamin G Vincent; Thomas B Kepler; Robert Maile; Jeffrey Frelinger; Edward J Collins
Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.
European journal of immunology 2008;38(6):1511-21.
2008: Matthew D Woolard; Lucinda L Hensley; Thomas H Kawula; Jeffrey Frelinger
Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.
Infection and immunity 2008;76(6):2651-9.
2008: Matthew D Woolard; Jeffrey Frelinger
Outsmarting the host: bacteria modulating the immune response.
Immunologic research 2008;41(3):188-202.
2007: Shaomin Tian; Robert Maile; Edward J Collins; Jeffrey Frelinger
CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(5):2952-60.
2007: Paul R Hess; Carie Barnes; Matthew D Woolard; Michael D L Johnson; John M Cullen; Edward J Collins; Jeffrey Frelinger
Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin.
Blood 2007;109(8):3300-7.
2007: T-P Zhang; Da-Yun Jin; R M Wardrop; Tong Gui; Robert Maile; Jeffrey Frelinger; Darrel W Stafford; Paul E Monahan
Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice.
Gene therapy 2007;14(5):429-40.
2007: Matthew D Woolard; Justin E Wilson; Lucinda L Hensley; Leigh A Jania; Thomas H Kawula; James R Drake; Jeffrey Frelinger
Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(4):2065-74.
2007: Carmen P Wong; Rosemary Stevens; Brian Long; Li Li; Yaming Wang; Mark A Wallet; Kevin S Goudy; Jeffrey Frelinger; Roland Tisch
Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(3):1388-95.
2006: Ian B Buchanan; Robert Maile; Jeffrey Frelinger; Jeffrey Fair; Anthony A Meyer; Bruce A Cairns
The effect of burn injury on CD8+ and CD4+ T cells in an irradiation model of homeostatic proliferation.
The Journal of trauma 2006;61(5):1062-8.
2006: Bruce A Cairns; Robert Maile; Carie M Barnes; Jeffrey Frelinger; Anthony A Meyer
Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury.
The Journal of trauma 2006;61(2):293-8; discussion 298-9.
2006: Robert Maile; Carie M Barnes; Alma I Nielsen; Anthony A Meyer; Jeffrey Frelinger; Bruce A Cairns
Lymphopenia-induced homeostatic proliferation of CD8+ T cells is a mechanism for effective allogeneic skin graft rejection following burn injury.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(11):6717-26.
2006: Carmen P Wong; Li Li; Jeffrey Frelinger; Roland Tisch
Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(3):1637-44.
2006: Robert Maile; Shannon M Pop; Roland Tisch; Edward J Collins; Bruce A Cairns; Jeffrey Frelinger
Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen.
European journal of immunology 2006;36(2):397-410.
2005: Robert E Johnston; Philip R Johnson; Mary J Connell; David C Montefiori; Ande West; martha collier; Chad Cecil; Ronald Swanstrom; Jeffrey Frelinger; Nancy L Davis
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.
Vaccine 2005;23(42):4969-79.
2005: Siobhán C Cowley; Elizabeth Hamilton; Jeffrey Frelinger; Jie Su; James Forman; Karen L Elkins
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
The Journal of experimental medicine 2005;202(2):309-19.
2005: Lisa Lindesmith; Christine Moe; Jacques LePendu; Jeffrey Frelinger; John Treanor; Ralph S Baric
Cellular and humoral immunity following Snow Mountain virus challenge.
Journal of virology 2005;79(5):2900-9.
2005: Jeffrey Fair; Bruce A Cairns; Michael Lapaglia; Montserrat Caballero; W Andrew Pleasant; Seigo Hatada; Hyung-Suk Kim; Tong Gui; Larysa Pevny; Anthony A Meyer; Darrel W Stafford; Oliver Smithies; Jeffrey Frelinger
Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(8):2958-63.
2005: Robert Maile; Catherine A Siler; Samantha E Kerry; Katherine E Midkiff; Edward J Collins; Jeffrey Frelinger
Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):619-27.
2005: Samantha E Kerry; Robert Maile; Edward J Collins; Jeffrey Frelinger
Memory CD8 T cells require CD8 coreceptor engagement for calcium mobilization and proliferation, but not cytokine production.
Immunology 2005;114(1):44-52.
2004: Philip A Stumbles; Robyn Himbeck; Jeffrey Frelinger; Edward J Collins; Richard A Lake; Bruce W S Robinson
Cutting edge: tumor-specific CTL are constitutively cross-armed in draining lymph nodes and transiently disseminate to mediate tumor regression following systemic CD40 activation.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(10):5923-8.
2004: Elizabeth Dees; Karen P McKinnon; Jennifer J Kuhns; Kathryn A Chwastiak; Scotty Sparks; Mary Myers; Edward J Collins; Jeffrey Frelinger; Hendrik W van Deventer; Frances A Collichio; Lisa A Carey; Mark E Brecher; Mark Graham II; Henry Earp; Jonathan S Serody
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer.
Cancer immunology, immunotherapy : CII 2004;53(9):777-85.
2003: Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula B Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey Frelinger
Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(9):4493-503.
2003: Anna K Nowak; Richard A Lake; Amanda L Marzo; Bernadette Scott; William R Heath; Edward J Collins; Jeffrey Frelinger; Bruce W S Robinson
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(10):4905-13.
2003: Scott A Gerber; James P Moran; john frelinger; Jeffrey Frelinger; Bruce M Fenton; Edith M Lord
Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts.
British journal of cancer 2003;88(9):1453-61.
2003: R Greenwood; Bo Wang; K Midkiff; Gilbert C White; H-F Lin; Jeffrey Frelinger
Identification of T-cell epitopes in clotting factor IX and lack of tolerance in inbred mice.
Journal of thrombosis and haemostasis : JTH 2003;1(1):95-102.
2003: Jennifer Buslepp; Samantha E Kerry; Doug Loftus; Jeffrey Frelinger; Ettore Appella; Edward J Collins
High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(1):373-83.
2002: Bo Wang; Ashawni Sharma; Robert Maile; Mohamed Saad; Edward J Collins; Jeffrey Frelinger
Peptidic termini play a significant role in TCR recognition.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(6):3137-45.
2002: Jeffrey Frelinger; Salisu Garba
Responses to smallpox vaccine.
The New England journal of medicine 2002;347(9):689-90; author reply 689-90.
2002: Nancy L Davis; Ande West; Elizabeth A Reap; Gene MacDonald; martha collier; Sergey A Dryga; Maureen F Maughan; Mary J Connell; Chris Walker; Kathryn McGrath; Chad Cecil; Li-Hua Ping; Jeffrey Frelinger; Robert Olmsted; Paula Keith; Ronald Swanstrom; Carolyn Williamson; Philip Johnson; David Montefiori; Robert E Johnston
Alphavirus replicon particles as candidate HIV vaccines.
IUBMB life 2002;53(4-5):209-11.
2002: Salisu Garba; Christopher D Pilcher; Andrea L Bingham; Joseph J Eron; Jeffrey Frelinger
HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(5):2247-54.
2001: Salisu Garba; Jeffrey Frelinger
Intracellular cytokine staining for TGF-beta.
Journal of immunological methods 2001;258(1-2):193-8.
2001: U M Abdel-Motal; Randall H Friedline; Brian Poligone; R R Pogue-Caley; Jeffrey Frelinger; Roland Tisch
Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Clinical immunology (Orlando, Fla.) 2001;101(1):51-8.
2001: Robert Maile; Bo Wang; W Schooler; Anthony A Meyer; Edward J Collins; Jeffrey Frelinger
Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(7):3708-14.
2001: Lorraine A Cramer; Jeffrey Frelinger
Dendritic cells transduced with HIV Nef express normal levels of HLA-A and HLA-B class I molecules.
Journal of acquired immune deficiency syndromes (1999) 2001;27(5):417-25.
2001: Bruce A Cairns; Robert Maile; Ian B Buchanan; D Pilati; Suzan DeSerres; Edward J Collins; Jeffrey Frelinger; Anthony A Meyer
CD8(+) T cells express a T-helper 1--like phenotype after burn injury.
Surgery 2001;130(2):210-6.
2001: Bo Wang; C C Norbury; R Greenwood; Jack R Bennink; jon yewdell; Jeffrey Frelinger
Multiple paths for activation of naive CD8+ T cells: CD4-independent help.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1283-9.
2001: R Greenwood; Jeffrey Frelinger
Mechanisms of unresponsiveness: T- and B-cell mediated mechanisms of anergy.
Advances in experimental medicine and biology 2001;489():109-17.
2000: Amanda L Marzo; Beverley F Kinnear; Richard A Lake; Jeffrey Frelinger; Edward J Collins; Bruce W S Robinson; Bernadette Scott
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(11):6047-55.
2000: Gilbert C White; R Greenwood; M Escobar; Jeffrey Frelinger
Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
Haematologica 2000;85(10 Suppl):113-6.
2000: Lawrence M Mylin; Todd D Schell; D Roberts; Mark J Epler; Alina Boesteanu; Edward J Collins; Jeffrey Frelinger; Sebastian JOYCE; Satvir S Tevethia
Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
Journal of virology 2000;74(15):6922-34.
2000: YP Wu; Eileen J McMahon; M R Kraine; Roland Tisch; A Meyers; Jeffrey Frelinger; Glenn K Matsushima; Koichi Suzuki
Distribution and characterization of GFP(+) donor hematogenous cells in Twitcher mice after bone marrow transplantation.
The American journal of pathology 2000;156(6):1849-54.
2000: Jonathan S Serody; Edward J Collins; Roland Tisch; Jennifer J Kuhns; Jeffrey Frelinger
T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4961-7.
2000: Bo Wang; Robert Maile; R Greenwood; Edward J Collins; Jeffrey Frelinger
Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(3):1216-22.
2000: Nancy L Davis; IJ Caley; K W Brown; MR Betts; David Irlbeck; K M McGrath; Mary J Connell; David C Montefiori; Jeffrey Frelinger; Ronald Swanstrom; Philip R Johnson; Robert E Johnston
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.
Journal of virology 2000;74(1):371-8.
1999: T J Kirksey; R R Pogue-Caley; Jeffrey Frelinger; Edward J Collins
The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes.
The Journal of biological chemistry 1999;274(52):37259-64.
1999: R R Caley; Amy Brewer; M Matsui; Jeffrey Frelinger
Analysis of the mutant HLA-A*0201 heavy chain H74L: impaired TAP-dependent peptide loading.
Human immunology 1999;60(9):743-54.
1999: MR Betts; JF Krowka; Thomas B Kepler; M Davidian; C Christopherson; S Kwok; L Louie; Joseph J Eron; Haynes W Sheppard; Jeffrey Frelinger
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
AIDS research and human retroviruses 1999;15(13):1219-28.
1999: IJ Caley; MR Betts; Nancy L Davis; Ronald Swanstrom; Jeffrey Frelinger; Robert E Johnston
Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy.
Vaccine 1999;17(23-24):3124-35.
1999: Donald N Cook; Oliver Smithies; R M Strieter; Jeffrey Frelinger; Jonathan S Serody
CD8+ T cells are a biologically relevant source of macrophage inflammatory protein-1 alpha in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(9):5423-8.
1999: Jonathan S Serody; Donald N Cook; Suzanne L Kirby; Elizabeth A Reap; Thomas C Shea; Jeffrey Frelinger
Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.
Blood 1999;93(1):43-50.
1998: John P Hunt; CT Hunter; MR Brownstein; A Giannopoulos; Charles Hultman; Suzan DeSerres; LW Bracey; Jeffrey Frelinger; Anthony A Meyer
The effector component of the cytotoxic T-lymphocyte response has a biphasic pattern after burn injury.
The Journal of surgical research 1998;80(2):243-51.
1998: Charles Hultman; John P Hunt; H Yamamoto; A Giannopoulos; Suzan DeSerres; Jeffrey Frelinger; Anthony A Meyer
Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens.
The Journal of trauma 1998;45(1):25-33; discussion 33-4.
1998: Edward J Collins; Jeffrey Frelinger
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes.
Immunological reviews 1998;163():151-60.
1998: John P Hunt; CT Hunter; MR Brownstein; Charles Hultman; Suzan DeSerres; LW Bracey; Jeffrey Frelinger; Anthony A Meyer
Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
The Journal of surgical research 1998;76(1):32-6.
1998: Jeffrey Frelinger; Jonathan S Serody
Immune response of beta 2-microglobulin-deficient mice to pathogens.
Current topics in microbiology and immunology 1998;232():99-114.
1997: Ann M Reed; Edward J Collins; L P Shock; David Klapper; Jeffrey Frelinger
Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(12):6260-5.
1997: MR Betts; JF Krowka; C Santamaria; K Balsamo; F Gao; G Mulundu; C Luo; N N'Gandu; Haynes W Sheppard; B H Hahn; Susan Allen; Jeffrey Frelinger
Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.
Journal of virology 1997;71(11):8908-11.
1997: Daniel G Quinn; A J Zajac; C E Hioe; Jeffrey Frelinger
Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.
Journal of virology 1997;71(11):8392-6.
1997: Charles Hultman; H Yamamoto; Suzan DeSerres; Jeffrey Frelinger; Anthony A Meyer
Early but not late burn wound excision partially restores viral-specific T lymphocyte cytotoxicity.
The Journal of trauma 1997;43(3):441-7.
1997: Jonathan S Serody; Mark E Brecher; Georgette Dent; Stuart Bentley; Jeffrey Frelinger; Thomas C Shea
A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes.
Cancer research 1997;57(8):1547-53.
1997: IJ Caley; MR Betts; David Irlbeck; Nancy L Davis; Ronald Swanstrom; Jeffrey Frelinger; Robert E Johnston
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
Journal of virology 1997;71(4):3031-8.
1996: A J Zajac; Daniel G Quinn; Philip L Cohen; Jeffrey Frelinger
Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(25):14730-5.
1996: Jeffrey Frelinger; Minnie McMillan
The role of peptide specificity in MHC class I-restricted allogeneic responses.
Immunological reviews 1996;154():45-58.
1996: Jonathan S Serody; R M Poston; D Weinstock; Roger Kurlander; Jeffrey Frelinger
CD4+ cytolytic effectors are inefficient in the clearance of Listeria monocytogenes.
Immunology 1996;88(4):544-50.
1996: Amy Brewer; L G Tussey; M Matsui; G Li; Daniel G Quinn; Jeffrey Frelinger
A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.
Immunity 1996;4(5):505-14.
1996: W Litaker; Amy Brewer; Jeffrey Frelinger
A physical map of the Q region of B1O.P.
Mammalian genome : official journal of the International Mammalian Genome Society 1996;7(3):200-5.
1996: M Matsui; R J Warburton; Patricia C Cogswell; Albert S Baldwin; Jeffrey Frelinger
Effects of HIV-1 Tat on expression of HLA class I molecules.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(3):233-40.
1995: Daniel G Quinn; A J Zajac; Jeffrey Frelinger
The cell-mediated immune response against lymphocytic choriomeningitis virus in beta 2-microglobulin deficient mice.
Immunological reviews 1995;148():151-69.
1995: Charles Hultman; Bruce A Cairns; H Yamamoto; Suzan DeSerres; Jeffrey Frelinger; Anthony A Meyer
The 1995 Moyer Award. The effect of burn injury on allograft rejection, alloantigen processing, and cytotoxic T-lymphocyte sensitization.
The Journal of burn care & rehabilitation 1995;16(6):573-80.
1995: A J Zajac; D Muller; K Pederson; Jeffrey Frelinger; Daniel G Quinn
Natural killer cell activity in lymphocytic choriomeningitis virus-infected beta 2-microglobulin-deficient mice.
International immunology 1995;7(10):1545-56.
1995: Charles Hultman; Bruce A Cairns; Suzan DeSerres; Jeffrey Frelinger; Anthony A Meyer
Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts.
Transplantation 1995;60(6):584-9.
1995: R R Pogue; Joseph J Eron; Jeffrey Frelinger; M Matsui
Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(18):8166-70.
1995: Charles Hultman; Bruce A Cairns; Suzan DeSerres; Jeffrey Frelinger; Anthony A Meyer
Early, complete burn wound excision partially restores cytotoxic T lymphocyte function.
Surgery 1995;118(2):421-9; discussion 429-30.
1995: C E Hioe; Jeffrey Frelinger
Alterations of a dominant epitope of lymphocytic choriomeningitis virus which affect class I binding and cytotoxic T cell recognition.
Molecular immunology 1995;32(10):725-31.
1995: L G Tussey; S Rowland-Jones; T S Zheng; M J Androlewicz; P Cresswell; Jeffrey Frelinger; Andrew J McMichael
Different MHC class I alleles compete for presentation of overlapping viral epitopes.
Immunity 1995;3(1):65-77.
1995: M Matsui; R J Moots; R J Warburton; Amy Brewer; L G Tussey; Daniel G Quinn; Andrew J McMichael; Jeffrey Frelinger
Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(3):1088-96.
1994: M Matsui; R J Moots; Andrew J McMichael; Jeffrey Frelinger
Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
Human immunology 1994;41(2):160-6.
1994: Glenn K Matsushima; M Taniike; L H Glimcher; M J Grusby; Jeffrey Frelinger; Kinuko Suzuki; Jenny P-Y Ting
Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy.
Cell 1994;78(4):645-56.
1994: Bruce A Cairns; Suzan DeSerres; M Matsui; Jeffrey Frelinger; Anthony A Meyer
Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response.
Transplantation 1994;58(1):67-72.
1994: Robert A Colbert; S L Rowland-Jones; Andrew J McMichael; Jeffrey Frelinger
Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703.
Immunity 1994;1(2):121-30.
1994: R J Warburton; M Matsui; S L Rowland-Jones; M C Gammon; G E Katzenstein; T Wei; M Edidin; H J Zweerink; Andrew J McMichael; Jeffrey Frelinger
Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. Effect on maturation and peptide presentation.
Human immunology 1994;39(4):261-71.
1994: L G Tussey; M Matsui; S Rowland-Jones; R Warburton; Jeffrey Frelinger; Andrew McMichael
Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(3):1213-21.
1994: M Matsui; Jeffrey Frelinger
Restoration of CTL recognition of a mutant FMP peptide by a compensatory change in HLA-A2.
Immunogenetics 1994;40(1):66-9.
1994: C E Hioe; D M McKinney; Jeffrey Frelinger; Minnie McMillan
Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.
Immunogenetics 1994;40(3):222-9.
1993: Daniel G Quinn; A J Zajac; Jeffrey Frelinger; D Muller
Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells.
International immunology 1993;5(10):1193-8.
1993: Bruce A Cairns; Suzan DeSerres; K Kilpatrick; Jeffrey Frelinger; Anthony A Meyer
Cultured keratinocyte allografts fail to induce sensitization in vivo.
Surgery 1993;114(2):416-22.
1993: Robert A Colbert; S L Rowland-Jones; Andrew J McMichael; Jeffrey Frelinger
Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(14):6879-83.
1993: M Matsui; C E Hioe; Jeffrey Frelinger
Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(2):674-8.
1992: R J Moots; N L Samberg; L Pazmany; Jeffrey Frelinger; Andrew J McMichael; Hans J Stauss
A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes.
European journal of immunology 1992;22(6):1643-6.
1992: K E LaPan; David Klapper; Jeffrey Frelinger
Production and characterization of two new mouse monoclonal antibodies reactive with denatured mouse class II beta chains.
Hybridoma 1992;11(2):217-23.
1992: D Muller; Beverly H Koller; J L Whitton; K E LaPan; K K Brigman; Jeffrey Frelinger
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.
Science (New York, N.Y.) 1992;255(5051):1576-8.
1992: T W Croghan; R Rapaport; Jeffrey Frelinger; Robert A Eisenberg; Philip L Cohen
Clonal analysis of peripheral T cell precursors in lpr mice.
Autoimmunity 1992;12(4):295-302.
1991: P M Day; Jeffrey Frelinger
Differential expression of Q4 proteins (Qb-1) in fibroblasts and lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(10):3427-33.
1991: L G Tussey; Jeffrey Frelinger
Detergent enhances binding of a secreted HLA-A2 molecule to solid phase peptides.
Human immunology 1991;32(3):183-93.
1991: J E Badley; Jeffrey Frelinger
Expression of a MHC non-classical class I gene, Q4, is similar to a classical class I gene, Dp.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1991;18(5-6):315-21.
1991: D Muller; K Pederson; R Murray; Jeffrey Frelinger
A single amino acid substitution in an MHC class I molecule allows heteroclitic recognition by lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(4):1392-7.
1991: K E LaPan; David Klapper; Jeffrey Frelinger
Production and characterization of a peptide specific, anti-major histocompatibility complex class II, monoclonal antibody.
Molecular immunology 1991;28(4-5):499-504.
1991: Giovanna Lombardi; M Matsui; R Moots; G Aichinger; S Sidhu; R Batchelor; A J McMichael; Jeffrey Frelinger; Robert Lechler
Structural relationship between HLA-A2-restricted and anti-A2 allospecific T-cell recognition: analysis by mutation of the codons for polymorphic and conserved residues.
Transplantation proceedings 1991;23(1 Pt 1):446-8.
1991: Giovanna Lombardi; M Matsui; R Moots; G Aichinger; S Sidhu; R Batchelor; Jeffrey Frelinger; Robert Lechler
Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants.
Immunogenetics 1991;34(3):149-56.
1991: R J Moots; M Matsui; L Pazmany; Andrew J McMichael; Jeffrey Frelinger
A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
Immunogenetics 1991;34(3):141-8.
1991: J A Harton; W Litaker; Jeffrey Frelinger; Gail A Bishop
Structure function analysis of the H-2 Abp gene.
Immunogenetics 1991;34(6):358-65.
1990: Jeffrey Frelinger; F M Gotch; H Zweerink; E Wain; Andrew J McMichael
Evidence of widespread binding of HLA class I molecules to peptides.
The Journal of experimental medicine 1990;172(3):827-34.
1990: R Murray; K Katoh; J Alexander; D Muller; K Pederson; Jeffrey Frelinger
Mutations in the alpha 1 domain of a class I gene define residues important for specific allorecognition.
Cellular immunology 1990;128(1):220-30.
1990: William R Heath; M E Hurd; R Murray; Jeffrey Frelinger; L A Sherman
Analysis of novel residues of class I involved in recognition by alloreactive T cells.
Immunogenetics 1990;32(2):138-41.
1990: J Alexander; John A Payne; B Shigekawa; Jeffrey Frelinger; Peter Cresswell
The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains.
Immunogenetics 1990;31(3):169-78.
1990: Gail A Bishop; C A Pennell; W Travis; G Haughton; Jeffrey Frelinger
Antibodies specific for Ig idiotype, but not isotype, can substitute for antigen to induce IgM secretion by a B cell clone.
International immunology 1990;2(4):285-90.
1989: G A Bishop; Jeffrey Frelinger
Haplotype-specific differences in signaling by transfected class II molecules to a Ly-1+ B-cell clone.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(15):5933-7.
1989: Glenn K Matsushima; Wendy Gilmore; N Casteel; Jeffrey Frelinger; Stephen A Stohlman
Evidence for a subpopulation of antigen-presenting cells specific for the induction of the delayed-type hypersensitivity response.
Cellular immunology 1989;119(1):171-81.
1989: J Alexander; John A Payne; R Murray; Jeffrey Frelinger; Peter Cresswell
Differential transport requirements of HLA and H-2 class I glycoproteins.
Immunogenetics 1989;29(6):380-8.
1989: T W Groghan; J L Davignon; J Evans; J P Allison; Robert A Eisenberg; Jeffrey Frelinger; Philip L Cohen
Diminished expression of the T cell receptor on the expanded lymphocyte population in MRL/Mp-lpr/lpr mice.
Autoimmunity 1989;2(2):97-111.
1988: R C Jambou; J N Snouwaert; G A Bishop; J R Stebbins; Jeffrey Frelinger; D M Fowlkes
High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9426-30.
1988: R Murray; K Pederson; H Prosser; D Muller; Clyde A Hutchison; Jeffrey Frelinger
Random oligonucleotide mutagenesis: application to a large protein coding sequence of a major histocompatibility complex class I gene, H-2DP.
Nucleic acids research 1988;16(20):9761-73.
1988: T Kanda; M J Macchi; K LaPan; M Darsley; E Appella; Jeffrey Frelinger
Cytotoxic T lymphocyte recognition of hybrid MHC class I molecules.
Journal of immunogenetics 1988;15(5-6):295-305.
1988: J P Woods; Jeffrey Frelinger; G Warrack; Joseph G Cannon
Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection.
Infection and immunity 1988;56(8):1950-5.
1988: R Murray; Clyde A Hutchison; Jeffrey Frelinger
Saturation mutagenesis of a major histocompatibility complex protein domain: identification of a single conserved amino acid important for allorecognition.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(10):3535-9.
1988: J E Badley; G A Bishop; T St John; Jeffrey Frelinger
A simple, rapid method for the purification of poly A+ RNA.
BioTechniques 1988;6(2):114-6.
1988: Jeffrey Frelinger
Gene regulation, organization and function.
Immunology today 1988;9(1):3-4.
1988: G A Bishop; M S McMillan; G Haughton; Jeffrey Frelinger
Signaling to a B-cell clone by Ek, but not Ak, does not reflect alteration of Ak genes.
Immunogenetics 1988;28(3):184-92.
1988: T Katagiri; B Schepart; T W Croghan; Jeffrey Frelinger; Robert A Eisenberg; Philip L Cohen
Southern blot analysis of major histocompatibility genes of lpr mice.
Experimental and clinical immunogenetics 1988;5(4):218-25.
1987: M J Palmer; Jeffrey Frelinger
Widespread transcription of a Qa region gene in adult mice.
The Journal of experimental medicine 1987;166(1):95-108.
1987: Jenny P-Y Ting; M Takiguchi; M Macchi; Jeffrey Frelinger
The expression and detection of MHC class I antigens on murine neuroblastoma and ependymoblastoma lines.
Journal of neuroimmunology 1987;14(1):87-98.
1987: K M Cozad; Jeffrey Frelinger
Elucidation of major histocompatibility complex gene function in the mouse through the techniques of molecular biology and classical immunology.
Progress in veterinary microbiology and immunology 1987;3():1-30.
1987: T Kanda; K LaPan; H Takahashi; E Appella; Jeffrey Frelinger
The alpha 1 and alpha 2 domains of H-2 class I molecules interact to form unique epitopes.
Immunogenetics 1987;25(2):110-5.
1987: M J Darsley; H Takahashi; M J Macchi; Jeffrey Frelinger; K Ozato; E Appella
New family of exon-shuffled recombinant genes reveals extensive interdomain interactions in class I histocompatibility antigens and identifies residues involved.
The Journal of experimental medicine 1987;165(1):211-22.
1986: B S Schepart; H Takahashi; K M Cozad; R Murray; K Ozato; E Appella; Jeffrey Frelinger
The nucleotide sequence and comparative analysis of the H-2Dp class I H-2 gene.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(9):3489-95.
1986: M Takiguchi; Jeffrey Frelinger
Induction of antigen presentation ability in purified cultures of astroglia by interferon-gamma.
The Journal of molecular and cellular immunology : JMCI 1986;2(5):269-80.
1986: Glenn K Matsushima; R C Harmon; Jeffrey Frelinger
A new murine lymphocyte alloantigen, Ly-27.2.
Immunogenetics 1986;23(6):406-8.
1985: Stephen A Stohlman; Glenn K Matsushima; N Casteel; Jeffrey Frelinger
The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells.
European journal of immunology 1985;15(9):913-6.
1985: B S Schepart; J G Woodward; M J Palmer; M J Macchi; P Basta; E McLaughlin-Taylor; Jeffrey Frelinger
Expression in L cells of transfected class I genes from the mouse major histocompatibility complex.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(16):5505-9.
1985: M J Palmer; D A Buck; Jeffrey Frelinger; P J Wettstein
Polymorphic class II sequences linked to the rat major histocompatibility complex (RT1) homologous to human DR and DQ sequences.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1450-5.
1985: M Takiguchi; Jenny P-Y Ting; S C Buessow; C Boyer; Y Gillespie; Jeffrey Frelinger
Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability.
European journal of immunology 1985;15(8):809-14.
1984: E McLaughlin-Taylor; J G Woodward; Minnie McMillan; Jeffrey Frelinger
Distinct epitopes are recognized by cytolytic T lymphocyte clones on the same class I molecule: direct demonstration using DNA-transfected targets and long-term cytolytic T cell clones.
European journal of immunology 1984;14(11):969-74.
1984: J G Woodward; Glenn K Matsushima; Jeffrey Frelinger; Stephen A Stohlman
Production and characterization of T cell clones specific for mouse hepatitis virus, strain JHM: in vivo and in vitro analysis.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(2):1016-21.
1984: J G Woodward; J O Fleming; Glenn K Matsushima; Jeffrey Frelinger; Stephen A Stohlman
Fine specificity and genetic restriction of T cell clones specific for mouse hepatitis virus, strain JHM.
Advances in experimental medicine and biology 1984;173():331-43.
1984: M J Macchi; J G Woodward; E McLaughlin-Taylor; J Griffin; L Hood; Jeffrey Frelinger
Cloning and identification of the H-2Dp gene.
Immunogenetics 1984;19(3):195-204.
1984: E McLaughlin-Taylor; J G Woodward; M J Macchi; Minnie McMillan; Jeffrey Frelinger
Functional characterization of the H-2Dp gene product.
Immunogenetics 1984;19(3):205-16.
1984: I Stroynowski; A Orn; R S Goodenow; Minnie McMillan; J Forman; P R Brayton; Jeffrey Frelinger; Leroy Hood
Cytotoxic T lymphocytes recognize determinants on the BALB/c-H-2Ld molecule controlled by alpha 1 and alpha 2 but not alpha 3 external domains.
Immunogenetics 1984;20(2):141-54.
1983: M Palmer; P J Wettstein; Jeffrey Frelinger
Evidence for extensive polymorphism of class I genes in the rat major histocompatibility complex (RT1).
Proceedings of the National Academy of Sciences of the United States of America 1983;80(24):7616-20.
1983: Jeffrey Frelinger; A Orn; P R Brayton; Leroy Hood
Use of cloned H-2 genes for study of H-2-restricted cytotoxicity: Ld is the LCMV restriction element for H-2d.
Transplantation proceedings 1983;15(4):2024-6.
1983: J O Fleming; Stephen A Stohlman; R C Harmon; M M Lai; Jeffrey Frelinger; Leslie P Weiner
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.
Virology 1983;131(2):296-307.
1983: F Santiago-Schwarz; J G Woodward; J F Dixon; J W Parker; Jeffrey Frelinger; R L O'Brien
Low-density mononuclear cells. Potent stimulators of the human MLR.
Transplantation 1983;35(5):463-9.
1983: Jenny P-Y Ting; D F Nixon; L P Weiner; Jeffrey Frelinger
Brain Ia antigens have a bone marrow origin.
Immunogenetics 1983;17(3):295-301.
1983: R C Harmon; N Stein; Jeffrey Frelinger
Monoclonal antibodies reactive with H-2 determinants.
Immunogenetics 1983;18(5):541-5.
1982: V S Rao; Jeffrey Frelinger; M S Mitchell
The role of Ia antigens and Fc receptor-bearing T-cells in the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
Cellular immunology 1982;74(2):370-82.
1982: D S Linthicum; Jeffrey Frelinger
Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes.
The Journal of experimental medicine 1982;156(1):31-40.
1982: A Orn; R S Goodenow; Leroy Hood; P R Brayton; J G Woodward; R C Harmon; Jeffrey Frelinger
Product of a transferred H-2Ld gene acts as restriction element for LCMV-specific killer T cells.
Nature 1982;297(5865):415-7.
1982: J G Woodward; A Orn; R C Harmon; R S Goodenow; Leroy Hood; Jeffrey Frelinger
Specific recognition of the product of a transferred major histocompatibility complex gene by cytotoxic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(11):3613-7.
1982: S W Hill; Jeffrey Frelinger
Genetic control of the immune response in chimeric mice.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(6):2704-8.
1982: R E Fournier; Jeffrey Frelinger
Construction of microcell hybrid clones containing specific mouse chromosomes: application to autosomes 8 and 17.
Molecular and cellular biology 1982;2(5):526-34.
1982: S A Stohlman; J G Woodward; Jeffrey Frelinger
Macrophage antiviral activity: extrinsic versus intrinsic activity.
Infection and immunity 1982;36(2):672-7.
1982: J G Woodward; B L Shigekawa; Jeffrey Frelinger
Bone marrow-derived cells are responsible for stimulation I region-incompatible skin graft rejection.
Transplantation 1982;33(3):254-9.
1982: R S Goodenow; Minnie McMillan; A Orn; M Nicolson; N Davidson; Jeffrey Frelinger; Leroy Hood
Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer.
Science (New York, N.Y.) 1982;215(4533):677-9.
1981: P J Wettstein; Jeffrey Frelinger
T lymphocyte responses to non-H-2 histocompatibility antigens. I. Role of Ly-1+2+ T cells as cytotoxic effectors and requirement for Ly-1+2+ T cells for optimal generation of cytotoxic effectors.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(1):43-6.
1981: Jenny P-Y Ting; B L Shigekawa; D S Linthicum; L P Weiner; Jeffrey Frelinger
Expression and synthesis of murine immune response-associated (Ia) antigens by brain cells.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(5):3170-4.
1981: M McMillan; Jeffrey Frelinger; P P Jones; D B Murphy; H O McDevitt; L Hood
Structure of murine Ia antigens. Two dimensional electrophoretic analyses and high pressure liquid chromatography tryptic peptide maps of products of the I-A and I-E subregions and of an associated invariant polypeptide.
The Journal of experimental medicine 1981;153(4):936-50.
1981: john frelinger; Jeffrey Frelinger; L Hood
Peptide map comparisons of epidermal and spleen H-2 molecules.
Immunogenetics 1981;12(5-6):569-77.
1981: F Lafay; S J Ewald; M McMillan; Jeffrey Frelinger; L Hood
Tryptic peptide map analyses of mouse transplantation antigens.
Immunogenetics 1981;12(1-2):21-32.
1981: S A Stohlman; Jeffrey Frelinger
Macrophages and resistance to JHM virus CNS infection.
Advances in experimental medicine and biology 1981;142():387-98.
1980: Jeffrey Frelinger; john frelinger
Bone marrow origin of Ia molecules purified from epidermal cells.
The Journal of investigative dermatology 1980;75(1):68-70.
1980: M L Phillips; J W Parker; Jeffrey Frelinger; R L O'Brien
Characterization of responding cells in oxidative mitogen stimulation. II. Identification of an Ia-bearing adherent accessory cell.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(6):2700-7.
1980: M L Phillips; P J Wettstein; R L O'Brien; J W Parker; Jeffrey Frelinger
Characterization of responding cells in oxidative mitogen stimulation. I. Ia+ cells and Ly-1+2+ cells are required for the proliferative response.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(6):2693-9.
1980: S W Hill; D E Kipp; I Melchers; Jeffrey Frelinger; E E Sercarz
Multiple H-2 and non-H-2 genes controlling the antilysozyme response: alternative gene constellations can lead to responsiveness.
European journal of immunology 1980;10(5):384-91.
1980: S A Stohlman; Jeffrey Frelinger; L P Weiner
Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(4):1733-9.
1980: J J Jandinski; J Li; P J Wettstein; Jeffrey Frelinger; David W Scott
Role of self carriers in the immune response and tolerance. V. Reversal of trinitrophenyl-modified self suppression of the B-cell response by blocking of H-2 antigens.
The Journal of experimental medicine 1980;151(1):133-43.
1980: M L Phillips; S W Hill; J W Parker; R L O'Brien; Jeffrey Frelinger
Characterization of responding cells in oxidative mitogen stimulation. III. Presence of I-A- and I-J, E, C-subregion gene products on the surface of required cells.
Immunogenetics 1980;10(2):133-40.
1979: Jeffrey Frelinger; P J Wettstein
Expression of lymphocyte differentiation antigens on cells responsive to H-2 mutant alloantigens.
Journal of the Reticuloendothelial Society 1979;26(Suppl):597-607.
1979: john frelinger; L Hood; S Hill; Jeffrey Frelinger
Mouse epidermal Ia molecules have a bone marrow origin.
Nature 1979;282(5736):321-3.
1979: P J Wettstein; D W Bailey; L E Mobraaten; J Klein; Jeffrey Frelinger
T lymphocyte response to H-2 mutants: cytotoxic effectors are Ly-1+2+.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(7):3455-9.
1979: T L Delovitch; A Fegelman; B H Barber; Jeffrey Frelinger
Immunochemical characterization of the Ly-8.2 murine lymphocyte alloantigen: possible relationship to actin.
Journal of immunology (Baltimore, Md. : 1950) 1979;122(1):326-33.
1978: Jeffrey Frelinger; F J Hibbler; S W Hill
Expression of I-A and I-E,C region-coded Ia antigens on functional B cell subpopulations.
Journal of immunology (Baltimore, Md. : 1950) 1978;121(6):2376-80.
1978: J P Allison; L E Walker; W A Russell; M A Pellegrino; S Ferrone; R A Reisfeld; Jeffrey Frelinger; J Silver
Murine Ia and human DR antigens: homology of amino-terminal sequences.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(8):3953-6.
1978: P J Wettstein; D W Bailey; L E Mobraaten; J Klein; Jeffrey Frelinger
T-lymphocyte response to H-2 mutants. I. Proliferation is dependent on Ly 1+2+ cells.
The Journal of experimental medicine 1978;147(5):1395-1404.
1977: P J Wettstein; G Haughton; Jeffrey Frelinger
H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. I. Donor H-2D region control of H-7.1-immunogenicity and lack of restriction in vivo.
The Journal of experimental medicine 1977;146(5):1346-55.
1977: J Silver; W A Russell; B L Reis; Jeffrey Frelinger
Chemical characterization of murine Ia alloantigens determined by the i-E/i-C subregions of the H-2 complex.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(11):5131-4.
1977: P J Wettstein; Jeffrey Frelinger
H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. II. H-2D region control of H-7.1-specific stimulator function in mixed lymphocyte culture and susceptibility to lysis by H-7.1-specific cytotoxic cells.
The Journal of experimental medicine 1977;146(5):1356-66.
1977: Jeffrey Frelinger
Ia-bearing cells promote the concanavalin A mitogenic response of Ia-negative T cells.
European journal of immunology 1977;7(7):447-50.
1977: O A Lukasewycz; Jeffrey Frelinger
Immune mechanisms in leukemia role of the Ia antigens.
The Journal of experimental medicine 1977;145(4):1077-81.
1977: E Dugan; John E Niederhuber; Jeffrey Frelinger; L Mayo; D C Shreffler
Con A induced suppressor cells: suppression with I region incompatibility.
Cellular immunology 1977;29(2):322-30.
1977: D C Shreffler; Chella S David; S E Cullen; Jeffrey Frelinger; John E Niederhuber
Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex.
Cold Spring Harbor symposia on quantitative biology 1977;41 Pt 2():477-87.
1976: Jeffrey Frelinger; John E Niederhuber; D C Shreffler
Effects of anti-Ia sera on mitogenic responses. III. Mapping the genes controlling the expression of Ia determinants on concanavalin A-reactive cells to the I-J subregion of the H-2 gene complex.
The Journal of experimental medicine 1976;144(4):1141-6.
1976: John E Niederhuber; Jeffrey Frelinger; E Dugan; D C Shreffler
The relationship of the major murine histocompatibility region associated IA antigens to mitogen responses.
The Journal of surgical research 1976;20(6):563-70.
1976: John E Niederhuber; Jeffrey Frelinger; M S Dine; P Shoffner; E Dugan; D C Shreffler
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells.
The Journal of experimental medicine 1976;143(2):372-81.
1976: John E Niederhuber; Jeffrey Frelinger
Expression of Ia antigens on T and B cells and their relationship to immune-response functions.
Transplantation reviews 1976;30():101-21.
1975: John E Niederhuber; Jeffrey Frelinger; E Dugan; A Coutinho; D C Shreffler
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera.
Journal of immunology (Baltimore, Md. : 1950) 1975;115(6):1672-6.
1975: Jeffrey Frelinger; John E Niederhuber; D C Shreffler
Inhibition of immune responses in vitro by specific antiserums to Ia antigens.
Science (New York, N.Y.) 1975;188(4185):268-70.
1975: J S Schultz; Jeffrey Frelinger; Sun Kee Kim; D C Shreffler
The distribution of Ia antigens of the H-2 complex on lymph node cells by immunoferritin labelling.
Cellular immunology 1975;16(1):125-34.
1974: Jeffrey Frelinger; J E Neiderhuber; Chella S David; D C Shreffler
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes.
The Journal of experimental medicine 1974;140(5):1273-84.
1974: Jeffrey Frelinger; D B Murphy; J F McCormick
Tla types of H-2 congenic and recombinant mice.
Transplantation 1974;18(3):292-4.
1974: Chella S David; Jeffrey Frelinger; D C Shreffler
New lymphocyte antigens controlled by the Ir-IgG region of the H-2 gene complex.
Transplantation 1974;17(1):122-5.
1973: Chella S David; Jeffrey Frelinger; D C Schreffler
Serologic detection of lymphocyte cell-surface antigens controlled by the Ir region of the H-2 gene complex.
Transplantation proceedings 1973;5(4):1815-6.
1973: Chella S David; D C Shreffler; Jeffrey Frelinger
New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(9):2509-14.
1972: Jeffrey Frelinger
The maintenance of transferrin polymorphism in pigeons (saccharomyces cerevisiae-eggwhite).
Proceedings of the National Academy of Sciences of the United States of America 1972;69(2):326-9.
1971: Jeffrey Frelinger; T F Roth
Synthesis and conservation of ribosomal RNA in adult mosquito ovaries.
Journal of insect physiology 1971;17(8):1401-10.
1971: Jeffrey Frelinger
Maternally derived transferrin in pigeon squabs.
Science (New York, N.Y.) 1971;171(3977):1260-1.